103 related articles for article (PubMed ID: 16055461)
1. Pharmacokinetics of a novel oral slow-release form of misoprostol.
Fiala C; Aronsson A; Granath F; Stephansson O; Seyberth HW; Watzer B; Gemzell-Danielsson K
Hum Reprod; 2005 Dec; 20(12):3414-8. PubMed ID: 16055461
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
Aronsson A; Fiala C; Stephansson O; Granath F; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
[TBL] [Abstract][Full Text] [Related]
3. Effects of slow release misoprostol on uterine contractility in early pregnancy.
Fiala C; Aronsson A; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2005 Sep; 20(9):2648-52. PubMed ID: 15919772
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of repeated doses of misoprostol.
Tang OS; Schweer H; Lee SW; Ho PC
Hum Reprod; 2009 Aug; 24(8):1862-9. PubMed ID: 19395364
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of pharmacokinetics of a single vaginal dose of dry misoprostol or misoprostol moistened with normal saline or with acetic acid.
Lee VC; Yung SS; Li RH; Watzer B; Schweer H; Ng EH; Ho PC
Hum Reprod; 2011 Nov; 26(11):2981-7. PubMed ID: 21908466
[TBL] [Abstract][Full Text] [Related]
6. Misoprostol administered by epithelial routes: Drug absorption and uterine response.
Meckstroth KR; Whitaker AK; Bertisch S; Goldberg AB; Darney PD
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):582-90. PubMed ID: 16946218
[TBL] [Abstract][Full Text] [Related]
7. Absorption kinetics of misoprostol with oral or vaginal administration.
Zieman M; Fong SK; Benowitz NL; Banskter D; Darney PD
Obstet Gynecol; 1997 Jul; 90(1):88-92. PubMed ID: 9207820
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.
Tang OS; Ho PC
Contraception; 2006 Jul; 74(1):26-30. PubMed ID: 16781256
[TBL] [Abstract][Full Text] [Related]
9. Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.
Sioutas A; Sandström A; Fiala C; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2012 Feb; 27(2):388-93. PubMed ID: 22128294
[TBL] [Abstract][Full Text] [Related]
10. Oral, rectal, and vaginal pharmacokinetics of misoprostol.
Khan RU; El-Refaey H; Sharma S; Sooranna D; Stafford M
Obstet Gynecol; 2004 May; 103(5 Pt 1):866-70. PubMed ID: 15121558
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of different routes of administration of misoprostol.
Tang OS; Schweer H; Seyberth HW; Lee SW; Ho PC
Hum Reprod; 2002 Feb; 17(2):332-6. PubMed ID: 11821273
[TBL] [Abstract][Full Text] [Related]
12. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial.
Oppegaard KS; Qvigstad E; Nesheim BI
BJOG; 2006 Jan; 113(1):58-64. PubMed ID: 16398773
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial.
Ayudhaya OP; Herabutya Y; Chanrachakul B; Ayuthaya NI; O-Prasertsawat P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S5-10. PubMed ID: 17726806
[TBL] [Abstract][Full Text] [Related]
14. Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
Schaff EA; DiCenzo R; Fielding SL
Contraception; 2005 Jan; 71(1):22-5. PubMed ID: 15639067
[TBL] [Abstract][Full Text] [Related]
15. Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparison.
Aronsson A; Helström L; Gemzell-Danielsson K
Contraception; 2004 Feb; 69(2):165-9. PubMed ID: 14759623
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
17. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases.
Goh SE; Thong KJ
Contraception; 2006 May; 73(5):516-9. PubMed ID: 16627037
[TBL] [Abstract][Full Text] [Related]
18. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
Kapp N; Borgatta L; Ellis SC; Stubblefield P
Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic profiles of controlled-release hydrogel polymer vaginal inserts containing misoprostol.
Powers BL; Wing DA; Carr D; Ewert K; Di Spirito M
J Clin Pharmacol; 2008 Jan; 48(1):26-34. PubMed ID: 18071191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
